Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- NTNU - Norwegian University of Science and Technology
- University of Bergen
- University of Oslo
- OsloMet
- BI Norwegian Business School
- Norwegian University of Life Sciences (NMBU)
- NTNU Norwegian University of Science and Technology
- UiT The Arctic University of Norway
- NHH Norwegian School of Economics
- NORCE
- Norwegian Meteorological Institute
- SINTEF
- Simula Metropolitan Center for Digital Engineering
- Østfold University College
- 4 more »
- « less
-
Field
-
Cancer Immunotherapy Group lead by Johanna Olweus, MD, PhD, at Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet and Institute for Clinical Medicine
-
responsible, and also have a great work capacity and enthusiasm for research Personal skills, including abilities to work independently and cooperate within a research group will be evaluated The candidate must
-
The Accounting group in the Department of Accounting of Operations Management is divided into two sub-groups: One group conducts quantitative (formal analytical and archival) research in the areas of financial
-
) 2023-2024, the Biomaterials group at the University of Oslo is a dynamic, world-leading research group. It has a strong international presence and is particularly active in securing grant funding and
-
innovation programme under grant agreement No 101226717. According to a recent Research Council of Norway (RCN) evaluation of medicine and health (EVALMEDHELSE) 2023-2024, the Biomaterials group
-
Group Context: The Analytics and AI Group includes 11 researchers and 2 PhD students. Focus areas: hybrid AI, reinforcement learning, model predictive control, industrial applications (robots, wastewater
-
internationally. Our collaborators include leading research groups in the UK, Denmark, and Spain – including the world-renowned High-Dimensional Neurology Group at UCL Queen Square Institute of Neurology in London
-
”. The position is in The Hortells lab , associated with the Cardiovascular Research Group . The position is available for commencement from January 2026 for a period of four years. The nominal length of the PhD
-
group may include security sensitive research. While not strictly required, eligibility for Norwegian security clearance is an advantage. Please see the attached link for more details and for
-
systems (RAS). You will be part of the Analysis and Control of Microbial Systems group (ACMS ), that is now integrated into the Microbial Biotechnology research group. We are passionate about conducting